September 17, 2020
Richmond, VA - Johnston-Willis Hospital has become the only Central Virginia hospital providing a new, incisionless treatment for medication-refractory essential tremor and tremor-dominant Parkinson's patients. The treatment uses focused ultrasound to treat deep within the brain with no surgical incision or implants.
The incisionless treatment, referred to as "Neuravive," uses sound energy to target and precisely treat a small area in the thalamus, considered to be responsible for causing tremor. The result for many patients is immediate improvement in their hand tremor with minimal complications reported. Neuravive is performed by trained physicians using Exablate Neuro, a focused ultrasound platform developed by global medical technology innovator INSIGHTEC.
"Focused ultrasound guided by magnetic resonance imaging provides patients suffering from debilitating tremor with an incisionless treatment option, which can often be performed on an outpatient basis with short recovery time," said Dr. K. Singh Sahni, Chairman of Neuroscience and Medical Director of the Gamma Knife Center at Johnston-Willis Hospital. "This non-invasive technology gives our patients more treatment options as they decide with their physicians the best course to get back to a more independent and active lifestyle. We are now one of the very few centers nationally capable of providing a choice of Focus Ultrasound, Gamma Knife as well as Deep Brain Stimulation to our patients with Parkinson's disease and essential tremors."
Essential tremors is the most common movement disorder, affecting millions of people worldwide. It typically involves tremor of the hands during movement such as eating and writing.